Willow Biosciences Inc. (the “Company”) (TSX: WLLW) (OTCQB: CANSF) announces the completion of the sale (the “Transaction”) of its wholly-owned operating subsidiary, Epimeron USA, Inc., to the U.S. subsidiary of Mycofeast Ltd., a privately-held, arms-length entity based in the United Kingdom (the “Purchaser”), pursuant to the terms of a share purchase agreement dated March 14, 2025 (the “Share Purchase Agreement”), between the Company and the Purchaser. The Transaction was completed for aggregate consideration equal to US$2.76 million in cash.
Read the full article: Willow Biosciences Inc. Announces Completion of Sale of Operating Subsidiary and Management Changes //
Source: https://www.prnewswire.com/news-releases/willow-biosciences-inc-announces-completion-of-sale-of-operating-subsidiary-and-management-changes-302443366.html